ARTICLE | Clinical News
Matrix Pharma regulatory update
June 10, 1996 7:00 AM UTC
MATX's Matrix Pharmaceutical Ltd. subsidiary received U.K. approval for AccuSite (fluorouracil/epinephrine) Injectable Gel to treat external genital warts. This is the first approval for a MATX-develo...